Juan Torres-Macho
Overview
Explore the profile of Juan Torres-Macho including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
664
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fernandez-de-Las-Penas C, Diaz-Gil G, Gil-Crujera A, Gomez-Sanchez S, Ambite-Quesada S, Torres-Macho J, et al.
Int J Mol Sci
. 2025 Mar;
26(5).
PMID: 40076720
Genetics and epigenetics are mechanisms proposed for explaining post-COVID-19 condition. This secondary analysis aimed to investigate if DNA methylation levels of the ACE2 promoter are different depending on the genotype...
2.
Franco-Moreno A, Madronal-Cerezo E, de Ancos-Aracil C, Farfan-Sedano A, Munoz-Rivas N, Bascunana Morejon-Giron J, et al.
Medicina (Kaunas)
. 2025 Jan;
61(1.
PMID: 39859000
: Venous thromboembolism (VTE) can be the first manifestation of an underlying cancer. This study aimed to develop a predictive model to assess the risk of occult cancer between 30...
3.
Torres-Macho J, Schutzer C
Med Clin North Am
. 2024 Nov;
109(1):31-45.
PMID: 39567100
Abdominal point-of-care ultrasound is an essential diagnostic tool for internal medicine physicians. It can identify intraperitoneal free fluid, evaluate the liver for size, presence of steatosis, and assessment for possible...
4.
Fernandez-de-Las-Penas C, Diaz-Gil G, Gil-Crujera A, Gomez-Sanchez S, Ambite-Quesada S, Franco-Moreno A, et al.
Biomedicines
. 2024 Aug;
12(8).
PMID: 39200127
One of theories explaining the development of long-lasting symptoms after an acute severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection include changes in the methylation pattern of the host. The...
5.
Franco-Moreno A, Acedo-Gutierrez M, Casado-Suela M, Labrador-San Martin N, de Carranza-Lopez M, Ibanez-Estellez F, et al.
Front Med (Lausanne)
. 2024 Aug;
11:1385833.
PMID: 39086948
Introduction And Objectives: Corticosteroids are among the drugs demonstrating a mortality benefit for coronavirus disease 2019 (COVID-19). The RECOVERY trial highlighted that dexamethasone reduced 28-day mortality for hospitalized COVID-19 patients...
6.
Fernandez-de-Las-Penas C, Diaz-Gil G, Gil-Crujera A, Gomez-Sanchez S, Ambite-Quesada S, Torres-Macho J, et al.
Microorganisms
. 2024 Jul;
12(7).
PMID: 39065072
It is known that SARS-CoV-2 can translocate via membrane ACE2 exopeptidase into the host cells, and thus hypomethylation of ACE2 possibly upregulates its expression, enhancing the risk of SARS-CoV-2 infection....
7.
Ryan P, Manzano S, Deihim-Rahampour N, Cuevas G, Martin-Gonzalez L, Gonzalez-Baeza A, et al.
Euro Surveill
. 2024 Jul;
29(29).
PMID: 39027943
BackgroundRecent migration trends have shown a notable entry of Latin American asylum seekers to Madrid, Spain.AimTo characterise the profile of asylum-seeking Latin American migrants who are living with HIV in...
8.
Fernandez-de-Las-Penas C, Franco-Moreno A, Ruiz-Ruigomez M, Arrieta-Ortubay E, Ryan-Murua P, Lumbreras-Bermejo C, et al.
Viruses
. 2024 Jun;
16(6).
PMID: 38932239
The aim of this study was to investigate the effects of administrating Remdesivir at the acute COVID-19 phase on developing post-COVID symptoms in previously hospitalized COVID-19 survivors by controlling factors...
9.
Munoz-Gomez M, Ryan P, Quero-Delgado M, Martin-Vicente M, Cuevas G, Valencia J, et al.
J Infect Public Health
. 2024 Jun;
17(7):102473.
PMID: 38865774
Background: Cancer patients often have weakened immune systems, resulting in a lower response to vaccines, especially those receiving immunosuppressive oncological treatment (OT). We aimed to assess the impact of OT...
10.
Fernandez-de-Las-Penas C, Torres-Macho J, Ruiz-Ruigomez M, Arrieta-Ortubay E, Rodriguez-Rebollo C, Akasbi-Moltalvo M, et al.
J Med Virol
. 2024 May;
96(5):e29676.
PMID: 38747018
The SARS-CoV-2 VIrus PERsistence (VIPER) study investigated the presence of long-lasting SARS-CoV-2 RNA in plasma, stool, urine, and nasopharyngeal samples in COVID-19 survivors. The presence of SARS-CoV-2 RNA reverse transcription...